The effect of Avastin on posterior capsular opacification after phacoemulsification: a randomized controlled trial
Not Applicable
- Conditions
- cataract.H28*
- Registration Number
- IRCT2017032531450N4
- Lead Sponsor
- Vice Chancellor for research of Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion:
Cataract patients undergoing surgical treatment for cataract in both eyes using phacoemulsification method.
Exclusion:
Eye trauma eye disease previous history of uveitis and collagen vascular diseases. Diabetic patients were removed from study to avoid bias.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Posterior lens capsule opacification after cataract surgery in patients with Avastin injection. Timepoint: Before the intervention, one month after the intervention and six months after the intervention and one year after the intervention. Method of measurement: Using the model PENTACAM OCULUS and densitometry DYSPLAY as little to check the status of posterior capsule opacification.;Posterior lens capsule opacification after cataract surgery in patients with BSS injection. Timepoint: Before the intervention, one month after the intervention and six months after the intervention and one year after the intervention. Method of measurement: ????? ????? ???? ??? ??? ?? ??? ????? ???????? ?? ??????? ?? ????? BSS.
- Secondary Outcome Measures
Name Time Method Posterior lens capsule opacification after cataract surgery in patients with Avastin injection. Timepoint: Before the intervention, one month after the intervention and six months after the intervention and one year after the intervention. Method of measurement: Using the model PENTACAM OCULUS and densitometry DYSPLAY as little to check the status of posterior capsule opacification.;Posterior lens capsule opacification after cataract surgery in patients with BSS injection. Timepoint: Before the intervention, one month after the intervention and six months after the intervention and one year after the intervention. Method of measurement: Using the model PENTACAM OCULUS and densitometry DYSPLAY as little to check the status of posterior capsule opacification.